Skip to main content

Table 4 Estimate of the annual economic burden of nosocomial S. aureus bloodstream infection in South Korea

From: The burden of nosocomial staphylococcus aureus bloodstream infection in South Korea: a prospective hospital-based nationwide study

  MRSA MSSA
Additional cost per patient ($) Annual number of patients Additional annual cost ($) Additional cost per patient ($) Annual number of patients Additional annual cost ($)
Medical cost, median       
Survivors 11,259 2003 22,551,777 4,797 847 4,063,059
Non survivors 14,772 943 13,929,996 408 139 56,712
Sub-total   2946 36,481,773   986 4,119,771
Cost of care giving      986  
Survivors 927 2003 1,857,327 818 847 693,000
Non survivors 273 943 257,182 0* 139  
Subtotal   2946 2,114,509   986 693,000
Productivity loss due to extended hospitalization     
Survivors Male 187 1368 255,546 165 425 70,051
Female 126 635 80,163 111 421 46,895
Non survivors Male 55 601 33,020 0* 59  
Female 37 342 12,698 0* 80  
Subtotal   2946 381,428   986 116,946
Productivity loss due to premature death 943 21,397,796   139 1,887,336
Total additional cost of nosocomial SA-BSI 2946 60,375,506   986 6,817,053
  1. Abbreviations: MRSA Methicillin-resistant S. aureus, MSSA Methicillin-susceptible S. aureus, SA-BSI S. aureus bloodstream infection.
  2. *Because hospital stays were shorter in the non-survivors in the MSSA group, no additional cost was generated.